David Lamond insider trades

Open-market stock purchases and sales by David Lamond, Unknown at Quince Therapeutics, Inc, from SEC Form 4 filings since May 13, 2019.

Recent trades

DateStockTradeValue
Jun 11, 2026QNCX Quince Therapeutics, IncBought (not open market)—
Jan 2, 2026QNCX Quince Therapeutics, IncBought (not open market)—

Companies traded

  • QNCX Quince Therapeutics, Inc: 15 buys, last Jun 11, 2026
  • CRTX Cortexyme, Inc: 17 buys, last Jun 8, 2022
  • LHDX Lucira Health, Inc: other filings, last Jun 1, 2022
  • AMTI Applied Molecular Transport Inc: 3 buys, last May 24, 2022

Get free alerts when David Lamond files a new trade →